product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-PLK1 (Thr210) Antibody
catalog :
5472S
quantity :
100 ul
price :
274 USD
clonality :
polyclonal
host :
rabbit
antigen modification :
phosphorylated
reactivity :
human
application :
western blot
more info or order :
Cell Signaling Technology product webpage
citations: 4
Published Application/Species/DilutionReference
  • western blot; human; 1:1000; fig 1
Wu J, Ivanov A, Fisher P, Fu Z. Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling. elife. 2016;5: pubmed publisher
  • western blot; human; fig 8
Thomas Y, Peter M, Mechali F, Blanchard J, Coux O, Baldin V. Kizuna is a novel mitotic substrate for CDC25B phosphatase. Cell Cycle. 2014;13:3867-77 pubmed publisher
  • western blot; human
Van Der Meer R, Song H, Park S, Abdulkadir S, Roh M. RNAi screen identifies a synthetic lethal interaction between PIM1 overexpression and PLK1 inhibition. Clin Cancer Res. 2014;20:3211-21 pubmed publisher
  • western blot; human
Danovi D, Folarin A, Gogolok S, Ender C, Elbatsh A, Engström P, et al. A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1. PLoS ONE. 2013;8:e77053 pubmed publisher
product information
SKU :
5472S
Product-Name :
Phospho-PLK1 (Thr210) Antibody
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H, (Mk)
Applications :
Western blot
Product-Category :
Cell Cycle / Checkpoint Control
Shipping-Temp :
COLD
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
62
Host :
Rabbit
Target :
PLK1 (Thr210) phosphate
Primary-Protein :
PLK1
Alt-Names :
PLK,PLK-1,PLK1,Polo-like kinase 1,STPK13,Serine/threonine-protein kinase 13,Serine/threonine-protein kinase PLK1,cell cycle regulated protein kinase,polo (Drosophia)-like kinase,polo like kinase,polo-like kinase 1 (Drosophila)
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.